Compounds of formula I are ligands for dopamine receptor subtypes within the body and are therefore useful in the treatment and/or prevention of disorders of the dopamine system, in particular schizophrenia. ##STR1## wherein Q is ##STR2##
公式I的化合物是体内
多巴胺受体亚型的
配体,因此在治疗和/或预防
多巴胺系统疾病,特别是精神分裂症方面非常有用。其中Q为##STR2##